ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Amneal Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Amneal Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.41%
EBIT Growth (5y)
30.81%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
5.35
Net Debt to Equity (avg)
-18.42
Sales to Capital Employed (avg)
0.98
Tax Ratio
44.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.67%
ROCE (avg)
9.50%
ROE (avg)
12.68%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
-17.93
EV to EBIT
13.13
EV to EBITDA
7.91
EV to Capital Employed
2.09
EV to Sales
1.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.90%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 351.01 MM
RAW MATERIAL COST(Y)
Fallen by -11.24% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3%
OPERATING PROFIT(Q)
Highest at USD 174.14 MM
OPERATING PROFIT MARGIN(Q)
Highest at 24.04 %
PRE-TAX PROFIT(Q)
Highest at USD 54.36 MM
NET PROFIT(Q)
Highest at USD 24.24 MM
EPS(Q)
Highest at USD 0.07
-2What is not working for the Company
INTEREST(Q)
At USD 65.1 MM has Grown at 14.33%
Here's what is working for Amneal Pharmaceuticals, Inc.
Pre-Tax Profit
At USD 54.36 MM has Grown at 222.71%
over average net sales of the previous four periods of USD 16.85 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 24.24 MM has Grown at 2,024.22%
over average net sales of the previous four periods of USD -1.26 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 351.01 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 174.14 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 24.04 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 54.36 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 24.24 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.07
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Inventory Turnover Ratio
Highest at 3%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -11.24% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Amneal Pharmaceuticals, Inc.
Interest
At USD 65.1 MM has Grown at 14.33%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
